ID: ALA4442299

Max Phase: Preclinical

Molecular Formula: C21H31N5O3

Molecular Weight: 401.51

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc(NC(=N)NC2(C(=O)N3CCN(C(C)=O)CC3)CCCCC2)cc1

Standard InChI:  InChI=1S/C21H31N5O3/c1-16(27)25-12-14-26(15-13-25)19(28)21(10-4-3-5-11-21)24-20(22)23-17-6-8-18(29-2)9-7-17/h6-9H,3-5,10-15H2,1-2H3,(H3,22,23,24)

Standard InChI Key:  IEYXYKRAGRFJLX-UHFFFAOYSA-N

Associated Targets(Human)

Endoplasmic reticulum aminopeptidase 1 581 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Endoplasmic reticulum aminopeptidase 2 387 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Interleukin-1 receptor antagonist protein 23 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 401.51Molecular Weight (Monoisotopic): 401.2427AlogP: 2.03#Rotatable Bonds: 4
Polar Surface Area: 97.76Molecular Species: BASEHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.97CX LogP: 1.29CX LogD: -0.90
Aromatic Rings: 1Heavy Atoms: 29QED Weighted: 0.53Np Likeness Score: -0.83

References

1. Maben Z, Arya R, Rane D, An WF, Metkar S, Hickey M, Bender S, Ali A, Nguyen TT, Evnouchidou I, Schilling R, Stratikos E, Golden J, Stern LJ..  (2020)  Discovery of Selective Inhibitors of Endoplasmic Reticulum Aminopeptidase 1.,  63  (1): [PMID:31841350] [10.1021/acs.jmedchem.9b00293]

Source